Lucid Diagnostics Inc LUCD

Morningstar Rating
$0.41 +0.01 (2.18%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LUCD is trading at a LOCK|H$^&> premium.
Price
$0.40
Fair Value
LOCK|m>ZK!K
Uncertainty
LOCK|MB YD@q
1-Star Price
LOCK|@<pf%>
5-Star Price
LOCK|V?k@!!q
Economic Moat
LOCK|mT^
Capital Allocation
—

News

Trading Information

Previous Close Price
$0.40
Day Range
$0.37–0.42
52-Week Range
$0.30–1.63
Bid/Ask
$0.41 / $0.41
Shares Outstanding
194.71M
Market Cap
$79.38M
Volume/Avg
3M / 5M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
11.95
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
82

Valuation

Metric
LUCD
Price/Earnings (Normalized)
—
Price/Book Value
12.94
Price/Sales
11.95
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
LUCD
Quick Ratio
0.87
Current Ratio
1.20
Interest Coverage
−2,872.82
Quick Ratio
LUCD

Profitability

Metric
LUCD
Return on Assets (Normalized)
−116.13%
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
−127.77%
Return on Assets
LUCD

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|kc&w@MLOCK|^p!J$181B
Medtronic PLC
MDT
LOCK|X<d#F^LOCK|&#%x$129B
Stryker Corp
SYK
LOCK|K!?pSLzLOCK|bm$121B
Boston Scientific Corp
BSX
LOCK|@VblWxtLOCK|N^cj$63B
Edwards Lifesciences Corp
EW
LOCK|&l?F$xKdLOCK|vY!p$61B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|@qQffbLOCK|ds$38B
DexCom Inc
DXCM
LOCK|dT<?#PGLOCK|?@Kf$31B
Koninklijke Philips NV ADR
PHG
LOCK|BnhLOCK|Q&#$29B
Steris PLC
STE
LOCK|%wY?#QLOCK|%HBzw$25B
Zimmer Biomet Holdings Inc
ZBH
LOCK|##w^#$X<LOCK|h%$20B

Sponsor Center